Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer.

In addition, we have previously reported an increase in AR levels in 65% of CRPC cases ( Edwards et al , 2001 ), which alone was not overly significant; however, combined with stabilisation through c-Jun and phosphorylation from the MAPK cascade, the small increase becomes highly significant with increased activity.

also in 132,142 other papers